Disease Prevention in Clinical Practice Base on Patient Specific Physiology
Launched by PACIFIC COAST FAMILY MEDICAL GROUP · Oct 11, 2017
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
It is well known that the Type 2 diabetes and vascular disease are preceded by over ten years by metabolic dysfunction and anatomic changes that can be quantified. In order to develop effective preventive strategies and reduce the cost burden to the health care system, recognition of the earliest pathophysiology of Type 2 diabetes and vascular disease is clinically relevant. In patients with risk factors for type 2 diabetes and/or vascular disease, we have quantified this dysmetabolic state using glucose tolerance testing to quantify insulin resistance and beta cell function while measuring...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • American Diabetic Association (ADA)/American Association of Clinical Endocrinologists (AACE) criteria for patients at risk for developing type 2 diabetes
- Exclusion Criteria:
- • Patients with prior treatment with medications for type 2 diabetes
About Pacific Coast Family Medical Group
Pacific Coast Family Medical Group is a leading healthcare organization dedicated to delivering high-quality, patient-centered care through innovative clinical research. With a focus on advancing medical knowledge and improving treatment options, the group conducts rigorous clinical trials across various therapeutic areas. Committed to ethical standards and patient safety, Pacific Coast Family Medical Group collaborates with experienced researchers and healthcare professionals to ensure the integrity and efficacy of its studies. Their mission is to enhance the health and well-being of the community by providing access to cutting-edge therapies and contributing to the development of new medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
John P Armato, MD
Principal Investigator
Providence St Josephs Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials